Related Experiment Videos
[Chemotherapy for colorectal carcinoma].
Hiroyuki Uetake1, Tetsuro Higuchi, Masayuki Enomoto
1Department of Digestive Surgery, Graduate School, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|December 4, 2003
Summary
First-line advanced colorectal cancer (CRC) treatment often uses 5-fluorouracil (5-FU) plus leucovorin (LV). Oral UFT and leucovorin (LV) show comparable efficacy with fewer side effects, while intrahepatic arterial infusion (IHA) requires further study for survival benefits.
Area of Science:
- Oncology
- Gastroenterology
- Medical treatment
Background:
- Advanced colorectal cancer (CRC) treatment relies heavily on intravenous 5-fluorouracil (5-FU) plus leucovorin (LV) as first-line therapy.
- Second-line treatment commonly involves CPT-11.
- Intrahepatic arterial infusion (IHA) shows promise for liver metastases, but survival data are pending.
Purpose of the Study:
- To evaluate the efficacy and safety of oral UFT and leucovorin (LV) combination therapy for advanced colorectal cancer (CRC).
- To assess the role of intrahepatic arterial infusion (IHA) in treating liver metastasis in CRC patients.
- To determine the survival benefit of adjuvant 5-fluorouracil (5-FU) and leucovorin (LV) after resection of Dukes' C CRC.
Main Methods:
- Review of randomized prospective studies comparing oral UFT/LV with standard chemotherapy.
- Analysis of response rates for intrahepatic arterial infusion (IHA) in liver metastasis.
- Evaluation of prospective studies on adjuvant 5-fluorouracil (5-FU) and leucovorin (LV) post-curative resection.
Main Results:
- Oral UFT and leucovorin (LV) demonstrate equal efficacy to standard regimens with improved tolerability.
- Intrahepatic arterial infusion (IHA) exhibits a high response rate for liver metastases.
- Six months of 5-fluorouracil (5-FU) and leucovorin (LV) post-adjuvant resection improves survival in Dukes' C CRC.
Conclusions:
- Oral UFT/LV offers a convenient and effective alternative for advanced colorectal cancer (CRC).
- Intrahepatic arterial infusion (IHA) warrants further investigation for survival benefits in liver metastasis.
- Adjuvant 5-fluorouracil (5-FU) and leucovorin (LV) are beneficial after curative resection for Dukes' C CRC.